Literature DB >> 9379023

Regulation of B cell functions by C3a and C3a(desArg): suppression of TNF-alpha, IL-6, and the polyclonal immune response.

W H Fischer1, T E Hugli.   

Abstract

Regulation of the humoral immune response by fragments of complement component C3 has been shown to play an important role in host defense. In this study, we investigated expression of the C3a receptor (C3aR) by human B cells and the effects of C3a and C3a(desArg) on IgG, TNF-alpha, and IL-6 production in Staphylococcus aureus Cowan strain I (SAC)/IL-2-activated B cells. Here we report that tonsil-derived human B cells express a C3aR that is indistinguishable at both the protein (by flow cytometry) and mRNA (by reverse transcription-PCR) levels from that on human neutrophils or on C3aR-transfected mouse L cells. Incubation of SAC/IL-2-activated B cells with C3a or C3a(desArg) resulted in a dose-dependent suppression of the polyclonal immune response. Under these same experimental conditions, IL-6 and TNF-alpha release was suppressed in a dose-dependent manner. Kinetic studies with SAC/IL-2-activated B cells revealed that C3a must be present at initiation of the culture to exert its suppressive effect on IgG and IL-6 production. These results demonstrate that tonsil-derived B cells express the C3aR and that C3a as well as C3a(desArg) have a direct immunomodulatory effect on these cells.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9379023

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  29 in total

Review 1.  Complement: a key system for immune surveillance and homeostasis.

Authors:  Daniel Ricklin; George Hajishengallis; Kun Yang; John D Lambris
Journal:  Nat Immunol       Date:  2010-08-19       Impact factor: 25.606

Review 2.  The role of complement in danger sensing and transmission.

Authors:  Jörg Köhl
Journal:  Immunol Res       Date:  2006       Impact factor: 2.829

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

4.  The receptor for the complement C3a anaphylatoxin (C3aR) provides host protection against Listeria monocytogenes-induced apoptosis.

Authors:  Stacey L Mueller-Ortiz; John E Morales; Rick A Wetsel
Journal:  J Immunol       Date:  2014-06-30       Impact factor: 5.422

5.  Cholinergic activation suppresses palmitate-induced macrophage activation and improves acylation stimulating protein resistance in co-cultured adipocytes.

Authors:  Jing Wu; Zhou-Yang Jiao; Rui-Zhen Li; Hui-Ling Lu; Hao-Hao Zhang; Katherine Cianflone
Journal:  Exp Biol Med (Maywood)       Date:  2017-03-20

Review 6.  Innate and adaptive immunologic functions of complement in the host response to Listeria monocytogenes infection.

Authors:  Daniel G Calame; Stacey L Mueller-Ortiz; Rick A Wetsel
Journal:  Immunobiology       Date:  2016-07-16       Impact factor: 3.144

7.  Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.

Authors:  J Zwirner; O Götze; G Begemann; A Kapp; K Kirchhoff; T Werfel
Journal:  Immunology       Date:  1999-05       Impact factor: 7.397

Review 8.  Anaphylatoxins: their role in bacterial infection and inflammation.

Authors:  Pieter-Jan Haas; Jos van Strijp
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

9.  Human monocyte-derived dendritic cells are chemoattracted to C3a after up-regulation of the C3a receptor with interferons.

Authors:  Ralf Gutzmer; Margarete Lisewski; Jörg Zwirner; Susanne Mommert; Carola Diesel; Miriam Wittmann; Alexander Kapp; Thomas Werfel
Journal:  Immunology       Date:  2004-04       Impact factor: 7.397

10.  Disruption of the C5a receptor gene increases resistance to acute Gram-negative bacteremia and endotoxic shock: opposing roles of C3a and C5a.

Authors:  Travis J Hollmann; Stacey L Mueller-Ortiz; Michael C Braun; Rick A Wetsel
Journal:  Mol Immunol       Date:  2007-12-11       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.